Trial intelligence / Profile preview

TCRαβ-depleted haploidentical HSCT in children and adolescents

NCT02014506Phase 2Unknown

Sponsor
Asan Medical Center
Start
Jan 2017
Primary completion
Dec 2018
Countries
1
01

Overview

Phase 2, open-label trial in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and 12 more, sponsored by Asan Medical Center. Status: unknown.

02

Conditions

acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)juvenile myelomonocytic leukemia (JMML)

Beyond the preview

Go deeper on NCT02014506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02014506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call